Actionnariat et activité des initiés pour ProQR Therapeutics N.V. (PRQR): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $1.86 |
| Capitalisation | $196M |
| Bourse | NASDAQ |
| Pays | NL |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $62.4M | $57.8M | $120.7M | $125.7M | $92.8M | $213.3M | $101.1M | $131.4M | $154.7M | $108.5M |
| Placements à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Créances | $1.7M | $563175 | $2.4M | $1.3M | $978840 | $935915 | $61.1M | $1.4M | $2.1M | $6.0M |
| Stocks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $65.4M | $60.7M | $123.9M | $128.7M | $97.9M | $217.8M | $164.8M | $133.6M | $159.3M | $117.6M |
| Immobilisations Corporelles | $3.6M | $3.0M | $2.1M | $2.7M | $22.8M | $19.9M | $17.3M | $18.7M | $14.6M | $14.8M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | $94927 | $46831 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Totaux | $69.1M | $63.8M | $126.0M | $131.9M | $120.8M | $238.3M | $182.8M | $152.3M | $173.9M | $132.4M |
| Dettes Fournisseurs | $345958 | $655636 | $154325 | $499512 | $270404 | $217205 | $418362 | $1.7M | $16568 | $349986 |
| Dette à Court Terme | 0 | $2.4M | 0 | $955247 | $2.9M | $7.2M | $4.1M | $1.8M | $4.6M | $5.2M |
| Passifs Courants | $7.1M | $10.2M | $9.3M | $12.3M | $12.6M | $31.4M | $22.4M | $37.8M | $40.3M | $38.1M |
| Dette à Long Terme | $4.8M | $6.3M | $8.0M | $14.3M | $19.8M | $44.7M | $4.6M | $4.7M | 0 | 0 |
| Passifs Totaux | $13.1M | $16.5M | $20.1M | $26.6M | $51.6M | $109.6M | $111.7M | $106.6M | $82.2M | $74.4M |
| Réserves | -$79.9M | -$143.3M | -$177.7M | -$237.7M | -$315.4M | -$361.4M | -$404.6M | -$442.8M | -$442.3M | -$549.1M |
| Capitaux Propres | $56.0M | $47.3M | $106.2M | $105.9M | $69.9M | $129.5M | $71.6M | $45.7M | $91.7M | $58.0M |
| Dette Totale | $4.8M | $8.7M | $8.0M | $15.2M | $41.9M | $68.7M | $23.4M | $21.8M | $16.1M | $16.4M |
| Dette Nette | -$57.6M | -$49.1M | -$112.7M | -$110.4M | -$50.9M | -$144.6M | -$77.7M | -$109.6M | -$138.6M | -$92.1M |
| Fonds de Roulement | $58.3M | $50.5M | $114.6M | $116.4M | $85.3M | $186.4M | $142.4M | $95.9M | $119.0M | $79.5M |
Santé financière
| Dette / Capitaux propres | 0.17 |
| Ratio de liquidité | 3.49 |
| Piotroski F-Score | 0 |
| Altman Z-Score | -4.56 |
Rentabilité
| Rentabilité des capitaux propres | -68.44% |
| Rentabilité du capital investi | -41.91% |
| Rentabilité des actifs | -31.76% |
| Marge brute | 92.33% |
| Marge opérationnelle | -232.71% |
| Marge nette | -228.29% |
Entreprises liées: ACHV · ALLO · ARCT · CAPR · EDIT · IMMP · MREO
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de PRQR: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions